RE:Q1 results Bloom Burton dropped the target price to $6.00 from $9.00 in March. Maintaining it at $6.00 now.
https://www.bloomburton.com/research/RX20200529.pdf
theinvestor22 wrote: Very nice results. COVID affected them in a positive way but, apparently Jan and Feb (pre-COVID) rev was up double digits, so underlying growth is there. Tiblella promotion starts in June and deliveries start in July. Combogesic probably won't be launched until later this year. An additional 332.4k shares were purchased under their existing NCIB after Q end at lovely rock bottom prices. (Way to go RX.)
I'm moving my fair value calc up. It's in the 9.50 range now and could go much higher after upcoming launches are in the results. Market still hasn't recognized it yet, but these things usually correct themselves over time.